Olimestra (Olmesartan Medoxomil)

Olmesartan Medoxomil, the active ingredient in Olimestra, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adult patients. GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Medoxomil is an ARB that lowers blood pressure by interfering with the renin‑angiotensin‑aldosterone system.

- Hypertension: Helps reduce systolic and diastolic blood pressure in adults. - Heart failure: Used as part of combination therapy to improve cardiac output and reduce hospitalisation risk. - Diabetic nephropathy : Slows the progression of kidney damage associated with type 2 diabetes. - Chronic vascular disease : Supports vascular health by de‑‑de‑de de de de etc

This      ....  .... .... .... ... ... .... .... … ...